Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive with type 2 diabetes: the SMOOTH study

Sharma, Arya M.; Davidson, Jaime; Koval, Stephen; Lacourcière, Yves
January 2007
Cardiovascular Diabetology;2007, Vol. 6, p28
Academic Journal
Background: The Study of Micardis (telmisartan) in Overweight/Obese patients with Type 2 diabetes and Hypertension (SMOOTH) compared hydrochlorothiazide (HCTZ) plus telmisartan or valsartan fixed-dose combination therapies on early morning blood pressure (BP), using ambulatory BP monitoring (ABPM). Methods: SMOOTH was a prospective, randomized, open-label, blinded-endpoint, multicentre trial. After a 2- to 4-week, single-blind, placebo run-in period, patients received once-daily telmisartan 80 mg or valsartan 160 mg for 4 weeks, with add-on HCTZ 12.5 mg for 6 weeks (T/HCTZ or V/HCTZ, respectively). At baseline and week 10, ambulatory blood pressure (ABP) was measured every 20 min and hourly means were calculated. The primary endpoint was change from baseline in mean ambulatory systolic and diastolic blood pressure (SBP; DBP) during the last 6 hours of the 24-hour dosing interval. Results: In total, 840 patients were randomized. At week 10, T/HCTZ provided significantly greater reductions versus V/HCTZ in the last 6 hours mean ABP (differences in favour of T/HCTZ: SBP 3.9 mm Hg, p < 0.0001; DBP 2.0 mm Hg, p = 0.0007). T/HCTZ also produced significantly greater reductions than V/HCTZ in 24-hour mean ABP (differences in favour of T/HCTZ: SBP 3.0 mm Hg, p = 0.0002; DBP 1.6 mm Hg, p = 0.0006) and during the morning, daytime and night-time periods (p < 0.003). Both treatments were well tolerated. Conclusion: In high-risk, overweight/obese patients with hypertension and type 2 diabetes, T/HCTZ provides significantly greater BP lowering versus V/HCTZ throughout the 24-hour dosing interval, particularly during the hazardous early morning hours.


Related Articles

  • Telmisartan in daily clinical practice: Factors affecting efficacy in treatment of primary arterial hypertension. Bergovac, M.; Knežević, A.; Plavec, S.; Trkulja, V. // Journal of Postgraduate Medicine;Jan-Mar2009, Vol. 55 Issue 1, p27 

    Background: Telmisartan provides effective treatment of hypertension in a broad spectrum of patients. Aims: To evaluate factors affecting the efficacy of telmisartan in daily clinical practice. Setting and Design: Prospective practice-based 12-week uncontrolled cohort study. Materials and...

  • Value of routine funduscopy in patients with hypertension: systematic review. Van den Born, Bert-Jan H.; Hulsman, Caroline A. A.; Hoekstra, Joost B. L.; Schlingemann, Reinier O.; Van Montfrans, Gert A. // BMJ: British Medical Journal (International Edition);7/9/2005, Vol. 331 Issue 7508, p73 

    Objective To evaluate the additional value of funduscopy in the routine management of patients with hypertension. Design Systematic review. Participants Adults aged 19 or more with hypertensive retinopathy. Data sources Medline, Embase, and the Cochrane Library from 1990. Review methods Studies...

  • Integrative Diabetes Management: A Case History. Braverman, Eric // Life Extension;Jul2005, Vol. 11 Issue 7, p66 

    This article focuses on a case history of diabetes. Edgar was a 51-year-old diabetic with multiple complaints when a physician first saw him five years ago. He had been using injectable insulin for several years to manage his blood sugar, but this married computer analyst and father of three...

  • Achieving Better Blood Pressure Control in High-Risk Patients with Type 2 Diabetes Using Combination Antihypertensive Therapy. Evans, Alison J.; Krentz, Andrew J. // Vascular Disease Prevention;Apr2007, Vol. 4 Issue 2, p111 

    Aims: To determine whether a short period of intensive monitoring and optimization of antihypertensive therapy according to a target-driven treatment protocol can improve blood pressure (BP) control in high-risk patients with type 2 diabetes. Methods: Consecutive patients (n=28, mean age 66...

  • C. Hypertension and Systemic Disease.  // Kidney;May/Jun2005, Vol. 14 Issue 3, p121 

    Presents abstracts of several studies on hypertension and systemic disease. "Blood Pressure Drugs Differ in Efficacy in Black Patients," by L. M. Brewster, G. A. van Montfrans and J. Kleijnen, published in the 2004 issue of "Annals of Internal Medicine"; "Possible Serum Marker for Preeclampsia...

  • Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: the Tarmidas study. de Pablos-Velasco, P.; Gonzalez-Albarran, O.; Estopiñan, V.; Khanbhai, A. // Journal of Human Hypertension;Aug2007, Vol. 21 Issue 8, p664 

    Numerous population studies confirm the high prevalence of hypertension in type II diabetic (DM2) subjects and that intensive antihypertensive treatment is more beneficial to diabetic than to nondiabetic hypertensive subjects, yet not many of these are specific to Spain. To assess the degree of...

  • Control of hypertension in diabetes. Bain, Steve; Samat, Ashish // GP: General Practitioner;8/18/2006, p22 

    The article discusses the effective control of blood pressure (BP) in the patients of diabetes. Researchers say that patients with type-1 diabetes are vulnerable to hypertension. To prevent any emergency, it is advised that BP readings should be taken over three to six months before considering...

  • What Was Normal Blood Pressure Is Now Considered Too High.  // Tufts University Health & Nutrition Letter;Jul2003, Vol. 21 Issue 5, p4 

    Reports on the introduction of the prehypertension category in the blood pressure guidelines of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure in the U.S., as of July 2003. Prevalence of prehypertension in the U.S.; Lifestyle changes...

  • Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase. Sarr, Mamadou; Chataigneau, Marta; Martins, Sandrine; Schott, Christa; El Bedoui, Jasser; Oak, Min-Ho; Muller, Bernard; Chataigneau, Thierry; Schini-Kerth, Val�rie B. // Cardiovascular Research;Sep2006, Vol. 71 Issue 4, p794 

    Abstract: Objective: Chronic administration of moderate amounts of red wine has been associated with a protective effect on the cardiovascular system. This study examined whether red wine polyphenols prevent the angiotensin II (Ang II)-induced hypertension and endothelial dysfunction in rats,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics